# Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

> **NCT03644342** · PHASE1,PHASE2 · TERMINATED · sponsor: **Michelle S Ludwig** · enrollment: 4 (actual)

## Conditions studied

- Metastatic Carcinoma of the Cervix

## Interventions

- **DRUG:** Nirapaib

## Key facts

- **NCT ID:** NCT03644342
- **Lead sponsor:** Michelle S Ludwig
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-15
- **Primary completion:** 2022-04-18
- **Final completion:** 2023-09-27
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** A recent change in treatment landscape may make study futile
- **Last updated:** 2024-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03644342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03644342, "Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03644342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*